Merck Takes A Shot At A June Approval For HPV Vaccine Gardasil
The firm requests a priority review for the human papillomavirus vaccine’s BLA, submitted Dec. 1.
The firm requests a priority review for the human papillomavirus vaccine’s BLA, submitted Dec. 1.